Member Info for Ollieh

Summit Therapeutics to Host First Quarter 2025 Financial Results & Operational Progress Call on May 1, 2025

That was last official release so what was coming on may the 1st.

Money raising? Maybe

Fingers crossed 🤞

But no news due so will it be a share issue.

Unless there's another share issue coming and market got a sniff, this is a very strange drop indeed.

Surly not just profit taking

Down 32% on no news...some shake that

Normal Friday end of month sell

Https://finance.yahoo.com/news/akeso-announces-fda-approval-penpulimab-001500455.html

https://finance.yahoo.com/news/akeso-announces-fda-approval-penpulimab-001500455.html

Not connected with summit but shows their ability to have fda approve one of their drugs, so they aren't misleading on data.

Gives confidence to the market at least.

Maybe.

But we're a some months from any fda news.

These trials and partnership news are starting to focus people's minds on potential here in my view.

🤞

Also remember the Pfizer partnership starts triles this summer .

Another potential jackpot in the future.

Remember we have the rights license for ivonescimab for almost the rest of the world.

So any trile from Akeso showing ivonescimab being effective on other cancer means the rest of the world come through summit for it.

All be it after more fda fast track triles for those other cancers.

So the potential is indeed huge .

Two times here in my opinion to make a few quid.

Sell on fda news and buy back on the dip into sales in future.

Hold for those numbers or more news and I'm out in retirement.

Premarket looks good for us today.

🤞

Https://finance.yahoo.com/news/ivonescimab-combination-chemotherapy-demonstrates-statistically-001600745.html

Ivonescimab looks to have a great future indeed.

Our first fda results this summer hopefully 🤞

China rest of most of world is where summit comes in hopefully

Passed equivalent to fda in China.

Has to do same testing for fda in us.

Hopefully same results.

New only months away now on trials, remember we're fast tracked here.

Test news in or around summer so not long now.

💪💪

Earnings shook some but what did people expect.

Other news was positive indeed so bring on fda results

Well Financials seem to have overpowered our other good news.

Do people think we are making money already?

Summer news will bring it higher.

The studies combining ivonescimab with Pfizer’s vedotin ADCs are planned to begin in the middle of this year. Further details on the clinical trials will be announced at a later date.

The goal of the collaboration is to evaluate ivonescimab, in combination with several unique Pfizer ADCs across multiple solid tumor settings to accelerate the advancement of potentially landscape-changing combinations, which seek to improve the standards of care for patients facing serious unmet needs.